Antibody shows weight loss, insulin benefits in study

11/28/2012 | U.S. News & World Report

A newly developed antibody called mimAb1, which mimics the function of a naturally occurring molecule called fibroblast growth factor 21, helped induce weight loss and improve insulin sensitivity and BMI in obese monkeys, researchers reported in Science Translational Medicine. However, researchers said it is still unclear how the treatment would work in human patients.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Principal, Global Compliance Operations
DJO Global
Vista, CA
Healthcare Compliance Manager
Ernst & Young
Multiple Locations, SL_Multiple Locations
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR